Home › Funds › Sofinnova Investments, Inc. › AVBP

Sofinnova Investments, Inc. position in AVBP

ARRIVENT BIOPHARMA INC COM · Health Care

Sofinnova Investments, Inc. reported holding 1,696,752 shares of AVBP (ARRIVENT BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$58.9M, representing 3.14% of its reported portfolio and ranking #7 among its reported holdings. Sofinnova Investments, Inc. has disclosed AVBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)1.70M sh
Reported value held$58.95M
Portfolio Weight3.14%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s AVBP position evolved

Sofinnova Investments, Inc. first disclosed a stake in AVBP in Q1 2024 at 1,696,752 shares (US$30.3M). The position peaked in Q2 2026 at 1,696,752 shares, worth US$58.9M. Across 10 filings, Sofinnova Investments, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,696,752 shares valued at US$58.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.70M $30.30M New
Q2 2024 1.70M $31.47M Hold
Q3 2024 1.70M $39.87M Hold
Q4 2024 1.70M $45.20M Hold
Q1 2025 1.70M $31.37M Hold
Q2 2025 1.70M $36.94M Hold
Q3 2025 1.70M $31.31M Hold
Q4 2025 1.70M $34.14M Hold
Q1 2026 1.70M $39.14M Hold
Q2 2026 1.70M $58.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVBP and 13F data

AVBP (ARRIVENT BIOPHARMA INC COM) is a Health Care company. 60 other funds we track also report a position in AVBP — the largest reported positions include MONTANOVA CAPITAL, LLC (US$156.9M), INFINITUM ASSET MANAGEMENT, LLC (US$154.2M), Hillhouse Capital (HHLR Advisors) (US$136.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVBP

All AVBP fund holders →

FAQ

How long has Sofinnova Investments, Inc. held AVBP?

Sofinnova Investments, Inc. has disclosed AVBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Sofinnova Investments, Inc.'s current position in AVBP?

As of Q2 2026, Sofinnova Investments, Inc. holds 1.70M shares of AVBP (ARRIVENT BIOPHARMA INC COM), valued at $58.95M, representing 3.14% of its reported portfolio and ranking #7.

Has Sofinnova Investments, Inc. been buying or selling AVBP?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in AVBP. The position peaked in Q2 2026 at 1.70M shares.

Which other funds hold AVBP?

Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Hillhouse Capital (HHLR Advisors), among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.